The firm is predicting a return to growth in its genotyping business later this year as it targets the single-cell analysis market with its eBioscience business.
A study involving more than 4,000 Huntington's disease cases led to variants on chromosomes 15 and 8 with ties to the age at which symptoms appear.
The firm posted revenues of $89 million driven by genetic analysis and product revenues, beating Wall Street estimates despite negative currency effects.
The firm will withdraw its planned IPO after being told that it would have to take a 30 to 40 percent discount to its valuation, its CEO said.
The lab has partnered with both WaferGen and Fluidigm to improve throughput for the barcode sequencing protocol it has developed for transcriptome profiling.
In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.
The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.
A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.
The US is heading toward another budget showdown, Nature News says.